Short Information | SELLAS Life Sciences Group Inc. (NASDAQ:SLS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,459,778 |
Total Actual Volume | 14,979,193 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 172,989 |
Average Short Percentage | 22.97% |
Is there a SLS Short Squeeze or Breakout about to happen?
See the SLS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-31-2024 | $1.39 | $1.41 | $1.4899 | $1.39 | 567,132 | 109,615 | 19.33% |
05-30-2024 | $1.34 | $1.4 | $1.44 | $1.34 | 477,270 | 122,295 | 25.62% |
05-29-2024 | $1.37 | $1.35 | $1.37 | $1.32 | 459,162 | 97,580 | 21.25% |
05-28-2024 | $1.39 | $1.38 | $1.4101 | $1.3201 | 532,057 | 95,516 | 17.95% |
05-24-2024 | $1.38 | $1.4 | $1.43 | $1.35 | 438,889 | 84,103 | 19.16% |
05-23-2024 | $1.47 | $1.35 | $1.47 | $1.3 | 978,212 | 242,179 | 24.76% |
05-22-2024 | $1.45 | $1.43 | $1.45 | $1.42 | 333,120 | 44,575 | 13.38% |
05-21-2024 | $1.48 | $1.42 | $1.5 | $1.4 | 804,501 | 209,756 | 26.07% |
05-20-2024 | $1.44 | $1.48 | $1.48 | $1.4 | 754,314 | 186,257 | 24.69% |
05-17-2024 | $1.48 | $1.46 | $1.52 | $1.44 | 1,138,481 | 118,158 | 10.38% |
05-16-2024 | $1.42 | $1.47 | $1.54 | $1.42 | 1,289,376 | 233,474 | 18.11% |
05-15-2024 | $1.35 | $1.47 | $1.48 | $1.34 | 1,452,340 | 333,121 | 22.94% |
05-14-2024 | $1.38 | $1.37 | $1.39 | $1.32 | 859,090 | 260,919 | 30.37% |
05-13-2024 | $1.37 | $1.37 | $1.4197 | $1.33 | 679,379 | 210,781 | 31.03% |
05-10-2024 | $1.33 | $1.355 | $1.42 | $1.2905 | 1,406,261 | 457,318 | 32.52% |
05-09-2024 | $1.285 | $1.29 | $1.325 | $1.26 | 471,359 | 106,575 | 22.61% |
05-08-2024 | $1.29 | $1.28 | $1.32 | $1.27 | 297,237 | 105,485 | 35.49% |
05-07-2024 | $1.28 | $1.32 | $1.34 | $1.27 | 547,937 | 98,310 | 17.94% |
05-06-2024 | $1.33 | $1.29 | $1.3385 | $1.25 | 706,203 | 143,353 | 20.3% |
05-03-2024 | $1.36 | $1.33 | $1.37 | $1.29 | 786,873 | 200,408 | 25.47% |
News, Short Squeeze, Breakout and More Instantly...
SELLAS Life Sciences Group Inc. Company Name:
SLS Stock Symbol:
NASDAQ Market:
Investors might want to bet on Galena Biopharma, Inc. (NASDAQ: SLS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...
- Announced Independent Data Monitoring Committee’s (IDMC) Recommendation to Continue the Phase 3 REGAL Study in Patients with Acute Myeloid Leukemia (AML) Without Modifications: IDMC to Reconvene in June - - Completed Enrollment in Phase 3 REGAL Study of Galinpepimut-S - ...
- The Company Filed IP Protection Related to the ASXL1 Mutation, a Highly Prevalent Gene Mutation in Myeloid Malignancies and Solid Tumors With Significant Market Potential – - 100% Overall Response Rate in Patients with ASXL1 Mutation in the SLS009 30mg BIW Cohort to Date, Al...